2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Poster Session

[P70] Poster Session 70 Cross-sectional Program(AE)

Kazuyo Nakamura1, Michihiro Kaya1, Ayumi Kinae1, Yoshimi Kubota1, Yuki Yanagisawa2, Keisuke Yamamoto3, Nana Takayashiki4, Hirotoshi Ukita4, Mariko Nagura5, Kaori Sugiue6, Mariko Kitajima7, Kumi Hirano8, Hiroki Ishida9, Chiharu Onoda10, Yutaka Kobayashi11, Eiji Nakatani12, Shoko Nanami13, Keiichi Odagiri14, Takaya Suzuki1 (1.Pharmaceutical Department, Shizuoka General Hospital, 2.Shizuoka Cancer Center, 3.Seirei Hamamatsu General Hospital, 4.Iwata City Hospital, 5.Chutoen General Medical Center, 6.Japanese Red Cross Shizuoka Hospital, 7.Shizuoka City Shizuoka Hospital, 8.Hamamatsu Medical Center, 9.JA Shizuoka Kohseiren Enshu Hospital, 10.Yaizu City Hospital, 11.Fujinomiya City General Hospital, 12.Shizuoka Graduate University of Public Health Corporation, 13.The Mt.Fuji Foundation for Healthcare Innovation and Cluster Development, 14.Center for Clinical Research, Hamamatsu University Hospital)

Emi Goto1,2, Takeo Hata1, Masami Nishihara1, Masashi Neo1, Mitsuhiko Iwamoto3, Kousei Kimura3, Masahiro Goto4, Yoshiyuki Rikitake2 (1.Department of Pharmacy, Osaka Medical and Pharmaceutical University Hospital, 2.Laboratory of Medical Pharmaceutics, Kobe Pharmaceutical University, 3.Department of Breast and Endocrine Surgery, Osaka Medical and Pharmaceutical University Hospital, 4.Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University Hospital)